[1]
J. E. Megias-Vericat, “DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA”, MJHID, vol. 11, no. 1, p. e2019016, Feb. 2019.